Treatment Registry
TR-0691 ActiveRecorded September 2, 2026

Compounded tirzepatide

Sold by iThriveMD · every compounded tirzepatide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

What you actually pay

Per month

$399

Medication · Monthly (no commitment), after first month$399

Added from the figures recorded below.

Price

TermPer monthCharged today
Monthly (no commitment), after first month

$100 Off $299.00 Billed every 28 days. No long-term commitment. $399.00 per month after

source

Per month$399Charged today$399
12-month plan (50% off)

12-month 50% Off $199.50 48 weeks paid upfront. Shipped every 28 days. Save $199.50 per month

source

Per month$199.50Charged today$2,394
Visit iThriveMD

We earn nothing from this link. iThriveMD has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

History

One reading so far. A price history appears here after the next verification pass.

  • September 2, 2026Entry added to the register

Sourcing and terms

Not yet checked: pharmacy, states, prescriber, cancellation, membership and consult fee.

Notes

  1. 1. September 2, 2026Local clinics in Southern/Northern California and Arizona plus a 'Virtual appointments/Telehealth' option. /policy/terms-of-use/ and /weight-loss/ pages returned essentially empty visible-text bodies to this tool (heavily JS-rendered), so states-served, prescriber sync/async, and cancellation policy could not be verified despite checking. Microdosing Tirzepatide plan description: 'This price covers your first 30-minute consultation, monthly 15-minute follow-up visits, and up to 3 mg of tirzepatide each week.'

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0691
Readings
1

Related records

What else iThriveMD sells

All iThriveMD programs and terms

Compounded tirzepatide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 307 records of the same molecule.

Cite this entry

Treatment Registry. (2026). iThriveMD compounded tirzepatide (TR-0691). Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0691

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.